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Hypothermia protects brain
mitochondrial function from hypoxemia
in a murine model of sepsis
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Abstract
Sepsis is commonly associated with brain dysfunction, but the underlying mechanisms remain unclear, although mito-
chondrial dysfunction and microvascular abnormalities have been implicated. We therefore assessed whether cerebral
mitochondrial dysfunction during systemic endotoxemia in mice increased mitochondrial sensitivity to a further bio-
energetic insult (hyoxemia), and whether hypothermia could improve outcome. Mice (C57bl/6) were injected intraper-
itoneally with lipopolysaccharide (LPS) (5mg/kg; n¼ 85) or saline (0.01ml/g; n¼ 47). Six, 24 and 48 h later, we used
confocal imaging in vivo to assess cerebral mitochondrial redox potential and cortical oxygenation in response to changes
in inspired oxygen. The fraction of inspired oxygen (FiO2) at which the cortical redox potential changed was compared
between groups. In a subset of animals, spontaneous hypothermia was maintained or controlled hypothermia induced
during imaging. Decreasing FiO2 resulted in a more reduced cerebral redox state around veins, but preserved oxidation
around arteries. This pattern appeared at a higher FiO2 in LPS-injected animals, suggesting an increased sensitivity of
cortical mitochondria to hypoxemia. This increased sensitivity was accompanied by a decrease in cortical oxygenation,
but was attenuated by hypothermia. These results suggest that systemic endotoxemia influences cortical oxygenation and
mitochondrial function, and that therapeutic hypothermia can be protective.
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Introduction
Sepsis is estimated to be the 11th most common cause
of death1 with a rising incidence due to an increasingly
aged and immunosuppressed population.2 Septic
patients commonly experience brain dysfunction,
ranging from mild confusion to coma, and this is asso-
ciated with increased mortality.3 Despite its prevalence
and severity, the mechanisms by which sepsis leads to
encephalopathy are still unclear. Sepsis is associated
with mitochondrial dysfunction in various organs
including skeletal muscle,4–6 liver,4,5,7–9 and kidney.10
Increasing evidence suggests that bioenergetic failure
plays an important role in the pathogenesis of organ
failure though this has not been deﬁnitively proven.
Indeed, it has been suggested that patients may die
not from the initial infection per se but rather because
of factors that persist even after the infection has been
successfully treated, such as a pronounced energy
imbalance11. Additionally, sepsis has been associated
with microvascular disturbances and poor organ perfu-
sion12–22 with reports of reduced cerebral blood ﬂow in
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patients23,24 and animal models.25,26 However, other
studies have failed to detect any abnormalities.27,28
If mitochondrial dysfunction and bioenergetic fail-
ure do play a key role, states which compromise energy
supply further (such as hypoxemia) would be expected
to be particularly detrimental in sepsis, whereas condi-
tions that reduce energy demand (such as hypothermia)
could provide protection. Indeed, hypothermia has
been successfully used in the treatment of several crit-
ical care conditions and has shown potential neuropro-
tective beneﬁts.29,30 However, a recent clinical study of
therapeutic hypothermia in bacterial meningitis was
prematurely abandoned due to increased risk of mor-
tality.31 In murine models of sepsis, hypothermia has a
rapid onset and the magnitude of change in body tem-
perature is related to reduced oxygen consumption and
increased mortality rates.32 Thus, the potential role of
therapeutic hypothermia remains uncertain.
We and others have previously shown that the
endogenous green ﬂuorescence of ﬂavoproteins can be
used to assess mitochondrial redox potential in vivo in
the central nervous system33,34 (for review, see Reinert
et al.35). Here, we have used this technique to assess
changes in cortical mitochondrial sensitivity to an
energetic challenge (hypoxemia) in a murine model of
endotoxic sepsis, induced via injection of the lipopoly-
saccharide (LPS) component of the Gram-negative bac-
terial cell wall to provoke a potent inﬂammatory
response. As such, LPS-induced endotoxemia can be
used to model the inﬂammatory component of sepsis.
We therefore used this model to assess cortical mito-
chondrial vulnerability during systemic inﬂammation,
and the eﬃcacy (or otherwise) of hypothermia in pro-
tecting mitochondrial function within the cerebral
cortex of endotoxic mice during hypoxemia.
Material and methods
Inbred mice (C57bl/6 strain, approximate 20 g body
weight) were housed on a 12 h light/dark cycle with
food and water available ad libitum. All experiments
were approved by the ethics committee of the
University College London, Institute of Neurology,
and licenced by the UK Home Oﬃce under the
Animals (Scientiﬁc Procedures) Act of 1986. The
ARRIVE guidelines were followed where appropriate.
Mice were injected with LPS (from Escherichia coli
0111:B4; Sigma-Aldrich, Poole, UK; i.p. 5mg/kg in
sterile normal saline, 0.01ml/g) or normal saline
alone, and then returned to their cages until terminal
surgery. The mice were randomized into nine groups
for imaging and four groups for oxygen measurements
(Table 1). The experimenter was not blinded. As the
results showed a recovery from LPS-induced endotox-
emia at 48 h, hypothermia treatment was not tested at
this time point. Additionally, induced hypothermia
(32C) was only applied to endotoxic and saline control
mice imaged 6 hours after injection, as the induced
hypothermia condition was studied to understand the
eﬀect of hypothermia on healthy mice.
Mice were terminally anesthetized using isoﬂurane
(2% in room air) either 6, 24 or 48 h after LPS injec-
tion as indicated (see Table 1). From this point
onwards, rectal temperature was measured and con-
trolled via a rectal probe and a homeothermic heating
mat maintained at either 37C (normothermia), 32C
(induced hypothermia), or the animal’s spontaneous
rectal temperature (spontaneous hypothermia). An inci-
sion was made in the scalp and connective tissue
removed. A titanium bar was aﬃxed to the skull
using dental cement (Contemporary Ortho-Jet
Powder, Lang Dental, Wheeling, US) mixed with
cyanoacrylate glue (Loctite, Henkel Ltd., Hatﬁeld,
UK). After the dental cement had dried (10min), a
partial craniotomy was performed over the right hemi-
sphere (5mm in diameter) exposing the underlying
cortex. The dura was kept intact and moistened and
cleaned with saline. In a subset of mice (n¼ 27),
oxygen-sensitive microbeads impregnated with a
phosphorescent dye, platinum(II)-5,10,15,20-tetra-
kis(2,3,4,5,6-pentaﬂuorophenyl)porphyrin (PtPFPP;
kindly provided by Luxcel Biosciences, Cork, Ireland)
were spread on the dura (5 ml of 5mg/ml aqueous sus-
pension). A 6mm diameter circular coverslip was
placed over the exposed cortex and sealed with petrol-
eum jelly to prevent evaporation of liquid during
imaging.
After surgery, mice were moved to a custom-made
stage on a LSM 5 Pascal laser-scanning confocal
microscope (Carl Zeiss, Jena, Germany). Endogenous
ﬂavoprotein ﬂuorescence (excitation: 488 nm, emission:
505–570 nm) and oxygen-sensitive microbeads
Table 1. Experimental conditions and numbers of animals used for flavoprotein imaging and oxygen probe experiments.
6 h post-LPS 24 h post-LPS 48 h post-LPS Saline
Flavoprotein imaging Normothermia (37C) 17 13 7 21
Spontaneous temperature 13 13 - 10
Induced hypothermia (32C) 13 - - 10
Oxygen probe measurements Normothermia (37C) 3 3 3 6
2 Journal of Cerebral Blood Flow & Metabolism
(excitation: 543 nm, emission: 650 nm, collected with
585 nm long pass ﬁlter) were imaged using time series
recording with an in-plane resolution of 512 by 512
pixels and an optical slice thickness of 896 mm.
During imaging, FiO2 was maintained for 5-min inter-
vals in sequence as follows: 0.21, 1.0, 0.21, 0.15, 0.21,
0.10, 0.21, 0.05 until death. Room air was delivered via
an air pump while variations in FiO2 were administered
as a mixture of oxygen and nitrogen.
For cortical oxygen tension studies, mice were
anesthetized as above using isoﬂurane (2% in room
air). Rectal temperature was measured and controlled
via a rectal probe and a homeothermic heating mat at
37C. A partial craniotomy was performed over the
right hemisphere (approximately 2mm). The dura
mater was removed and the ﬁber-optic tip of an
oxygen microsensor (OxyMicro, World Precision
Instruments, Hitchin, UK) was inserted into the
cortex using a micromanipulator in order to detect
luminescence quenching. The probe was inserted to a
depth of 700 mm followed by a retraction of 100 mm to a
ﬁnal recording depth of 600 mm from the cortical sur-
face. Cortical tissue oxygen tension (PtO2) was mea-
sured continuously during changes in inspired oxygen
as follows: 0.21, 0.15, 0.21, 0.10, 0.21, 0.05, for 5min
each, until death.
Heart rate was recorded in a subset of animals
(n¼ 53) using conventional electrophysiological equip-
ment (Neurolog, Digitimer, Welwyn Garden City,
Herts, UK). A reference electrode (hypodermic
needle) was inserted in the right hind foot, a ground
electrode was inserted subcutaneously into the back,
and a recording electrode was inserted subcutaneously
in the chest wall. The ECG record was displayed on a
digital oscilloscope (Sigma 60, Nicolet Technologies,
Madison, WI, USA) and heart rate recorded.
Confocal images were processed using Fiji/ImageJ
Version 1.48v (NIH, Bethesda, MD). Following align-
ment of time lapse recordings (using the ‘Stackreg’-
Plugin), three representative areas immediately adja-
cent to arteries (periarterial) and three areas adjacent
to veins (perivenous) were free-hand selected in each
time-lapse series for each animal (see Figure 2(a) for
example selections) and the ﬂuorescence intensity nor-
malized to the initial room air condition for each area.
The ratio of periarterial and perivenous ﬂuorescence
intensity during the last ﬁve cycles of each FiO2
manipulation (0.21, 1.0, 0.21, 0.15, 0.21, 0.10, 0.21,
0.05) were recorded until death. Up to eight oxygen-
sensitive phosphorescent beads were selected per time-
lapse and their ﬂuorescence intensity normalized to the
initial room air conditions. The normalised intensity
was then determined for the last ﬁve cycles of the
FiO2 manipulations, as with ﬂavoprotein ﬂuorescence.
Cortical tissue oxygenation, as recorded by the oxygen
sensor, was averaged over the last minute of the FiO2
manipulations.
Data are displayed as mean standard error of the
mean (SEM). Statistical analysis between experimental
groups was conducted using the IBM SPSS Statistics 22
package (SPSS, Chicago, IL, USA).
Results
Clinical features and outcomes
Mice injected with LPS displayed clinical features
including decreased activity, somnolence, hunched
appearance, piloerection, ocular discharge, hypother-
mia, and weight loss (Table 2).
Body temperature dropped signiﬁcantly at 6 h
(33.1 0.4C; t¼ 6.611,df¼ 40.710 (adjusted for inequal-
ity of variance), p< 0.001) and 24h (33.0 0.7C;
t¼ 4.381, df¼ 19.757 (adjusted for inequality of vari-
ance), p< 0.001), but not at 48 hours (35.6 0.6C;
t¼ 0.722, df¼ 23, p¼ 0.477) after LPS injection as com-
pared with saline controls (35.9 0.1C). A positive cor-
relation was seen between weight loss and temperature at
24h after LPS injection (r¼ 0.798, df¼ 17, p< 0.001;
Spearman’s rank correlation coeﬃcient) with more
weight loss evident in warmer mice.
When temperature was controlled at 37C, heart rate
did not diﬀer between LPS- and saline-injected mice.
However, spontaneous hypothermia reduced heart
rate signiﬁcantly at both 6 h (t¼ 4.548, df¼ 9.171
(adjusted for inequality of variance), p¼ 0.001) and
24 h (t¼ 2.950, df¼ 18, p¼ 0.009) after LPS injection
(Figure 1a).
Survival during decreased FiO2 was reduced in LPS-
injected mice compared with saline-injected controls,
but spontaneous hypothermia signiﬁcantly improved
resilience to increased levels of hypoxemia at 6 h post-
LPS injection (Figure 1b): during progressive hypox-
emia, LPS-injected mice died at higher FiO2 values
compared to saline-injected controls [t¼ 9.050,
df¼ 44.291 (adjusted for inequality of variance),
p< 0.001]. However, hypothermia (both spontaneous
and induced) improved tolerance to hypoxemia in endo-
toxic mice 6 h after LPS (t¼ 4.803, df¼ 28, p< 0.001
Table 2. Change in weight (g) of mice 6, 24 and 48 h after an
injection of saline or LPS.
Saline LPS
6 h 0.35 (0.08) 0.7 (0.05)**
24 h þ 0.42 (0.36) 1.91 (0.12)***
48 h þ 0.37 (0.27) 2.01 (0.44)***
Mean SEM. **p 0.01. ***p 0.001.
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and t¼ 2.868, df¼ 28, p¼ 0.008, respectively)
(Figure 1b).
Flavoprotein redox state
We previously reported that healthy animals subjected
to hypoxemia showed a characteristic change in the
distribution of cortical ﬂavoprotein ﬂuorescence,
exposing areas of vulnerability, revealed by decreased
ﬂuorescence (which reﬂects a more reduced state of the
ﬂavoprotein pool) distal to arteries and adjacent to
veins. However, ﬂavoprotein ﬂuorescence intensity
was preserved near arteries (Figure 2), forming an
‘arterial halo’ pattern. In animals injected with normal
saline, this arterial halo pattern appeared at the same
FiO2, regardless of the time from injection (data not
shown) and therefore data from mice injected with
saline were pooled. On breathing room air, the ﬂavo-
protein signal covered the cortex uniformly with no
diﬀerence between periarterial and perivenular ﬂuores-
cence, and this did not change when FiO2 was increased
to 100% in all groups (Figure 2b). In saline-injected
animals, exposure to 15% inspired oxygen also failed
to alter the distribution of the cortical ﬂavoprotein
signal. However, on decreasing the inspired oxygen to
10%, a change in cortical ﬂavoprotein ﬂuorescence was
seen in 11 of 21 saline-injected mice with the appear-
ance of the characteristic arterial halo pattern. All but
two of the remaining animals showed this pattern when
FiO2 was further reduced to 5% (Figure 2).
In contrast, at 6 h post-injection, the arterial halo
pattern appeared in the majority (9/17) of animals
injected with LPS even when breathing 15% O2
(Figure 2). At 24 h post-LPS, this sensitivity of the
ﬂavoprotein signal to changes in inspired oxygen was
attenuated: the arterial halo pattern appeared at FiO2
values between 0.10 and 0.15 in 77% of animals (10/13;
Figure 2). By 48 h post-LPS, clinical signs, survival and
ﬂavoprotein sensitivity to changes in inspired oxygen
did not diﬀer from saline-injected controls (Figures
1(b) and 2).
Changes in ﬂavoprotein ﬂuorescence with hypox-
emia were reversible when FiO2 was returned to 0.21
in all surviving animals. Here, the periarterial ﬂavopro-
tein signal expanded until it again covered the cortex
uniformly and the ratio of periarterial to perivenular
ﬂuorescence returned back to 1 (Figure 2b).
Cortical tissue oxygenation
The cortical PtO2 of saline-injected control mice while
breathing room air was higher (46.5 3.0mmHg) than
mice injected with LPS at both 6 h (29.3 5.6mmHg;
t¼ 3.044, df¼ 7, p¼ 0.01, single tailed t-test) and 24 h
(34.3 6.1mmHg; t¼ 2.071, df¼ 7, p¼ 0.039, single
tailed t-test). This pattern persisted at lower FiO2
although the diﬀerences were not always signiﬁcant
(Figure 3a). At 48 h, the cortices of LPS-injected ani-
mals had recovered to control PtO2 levels
(46.9 5.9mmHg, Figure 3a). A reduced cortical
PtO2 on decreasing the FiO2 was conﬁrmed in imaging
experiments using oxygen-sensitive phosphorescent
microbeads (Figure 3b).
Cortical redox changes in response to hypoxemia
during hypothermia (spontaneous or induced)
The rectal temperature of saline-injected mice was
35.9 0.1C. The arterial halo pattern response to
diﬀerences in FiO2 in these mice was very similar to
saline-injected mice kept at 37C (see above). The
mean temperature in LPS-injected mice was
Figure 1. (a) No change in heart rate was seen at 6 or 24 h post-injection of LPS in normothermic mice. However, at their
spontaneous temperature, endotoxic mice had a significantly lower heart rate. **p 0.01, ***p 0.001. (b) Mortality of mice sub-
jected to systemic inflammation/saline and hypoxemia. Data are displayed as mean SEM.
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signiﬁcantly lower at 6 h after injection [33.1 0.4C;
t¼ 6.611, df¼ 40.710 (adjusted for inequality of vari-
ance), p< 0.001]. If this spontaneous hypothermia was
maintained during imaging, the cortical mitochondria
were protected relative to normothermic (37C) LPS-
injected mice, such that the observed arterial halo
pattern response to changes in FiO2 was similar to
saline-injected controls (Figure 4), accompanied by an
improvement in survival during hypoxemia (Figure 1b).
However, this protective eﬀect was not seen at 24 h
after injection, despite the LPS-injected mice still
having a lower baseline mean temperature
Figure 2. The sensitivity of flavoprotein signal to changes in inspired oxygen is affected by systemic inflammation. (a) Flavoprotein
signal changes in endotoxic and control mice with changes in inspired oxygen. Blue¼ representative selection of perivenular tissue;
red¼ representative selection of periarterial tissue. Scale bar is 200 mm. (b) Quantification of the change in endogenous flavoprotein
fluorescence around veins relative to arteries. Data are displayed as meanþ SEM. **p (saline vs 6 h LPS) 0.01.
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(33.0 0.7C) than saline-injected controls (Figures
1(b) and 4). However, it should be noted that fewer
normothermic (37C), LPS-injected animals survived
surgery 24 hours after injection compared to those in
which spontaneous hypothermia was maintained. Data
from this group of animals were not included as no
imaging data could be collected.
As we observed a protective eﬀect of hypothermia in
LPS-injected animals at 6 h, we sought to determine the
eﬀects of hypothermia on saline-injected controls.
Induced hypothermia (32C) was protective for both
saline- and LPS-injected mice (Figure 5) with mortality
and the arterial halo pattern response not appearing
until a lower FiO2 was administered (Figure 5): only
53% of normothermic animals (9/17) survived on redu-
cing inspired oxygen to 15% at 6 h post-LPS compared
to all but one surviving (12/13) when kept under
induced hypothermia, and 100% (13/13) surviving
when spontaneous hypothermia was maintained.
Discussion
We report that in mice, endotoxemia temporarily
increases mortality and cortical mitochondrial
vulnerability (as assessed by ﬂavoprotein ﬂuorescence)
in response to hypoxemia, and that these LPS-induced
vulnerabilities are enhanced when animals are forcibly
kept at an increased core body temperature of 37C.
Bioenergetic failure is postulated to be an important
cause of multiple organ dysfunction in sepsis.36 Here we
investigated whether an additional bioenergetic chal-
lenge, namely hypoxemia, promotes further mitochon-
drial dysfunction in the cortices of mice subjected to
mild systemic inﬂammation. We report, in agreement
with previous work, that mitochondrial dysfunction,
deﬁned by a loss of ﬂavoprotein signal (i.e. increased
reduced state of the ﬂavoprotein pool37), is very pro-
nounced during hypoxemia, revealing areas of vulner-
ability in the cortex between vessels and surrounding
veins, yet with protected ‘halos’ close to arteries in
which the ﬂavoprotein pool remains oxidised.33,38
Importantly, areas of vulnerability and increased mor-
tality were observed at higher concentrations of
inspired oxygen in animals during systemic inﬂamma-
tion. This eﬀect was most pronounced at 6 h after LPS
injection but had returned to control levels by 48 h. The
present ﬁndings suggest that either mitochondrial dys-
function and/or organ hypoperfusion (macro and/or
microvascular) is involved in the pathology of
endotoxemia.
Previous reports of microvascular disturbances in
sepsis15–17,23,24 and our own observation that mito-
chondrial vulnerability in the endotoxic brain conforms
precisely to the vascular anatomy, strongly implicate
compromised oxygen availability and/or altered mito-
chondrial oxygen consumption. Therefore, we mea-
sured oxygen within the cortex, revealing that cortical
tissue oxygen tension was lower in endotoxic animals
than healthy controls. The lowest values of cortical
tissue oxygen were measured 6 h after LPS injection
with a partial recovery by 24 h, and returned to control
levels by 48 h after LPS injection. This coincided with
the increased vulnerability of LPS-injected mice to hyp-
oxemia, and supports evidence implicating microvascu-
lar dysfunction as a leading cause of multiple organ
dysfunction.15–17,23,24 As a limitation of this model,
ﬂuid resuscitation was not given so underlying hypo-
volemia in the endotoxic mice may have exacerbated
the impact of the hypoxemic insult. Changes in cerebral
oxygenation in response to reductions in FiO2 were
conﬁrmed in imaging experiments using oxygen-sensi-
tive microbeads.
The literature on the eﬀect of therapeutic hypother-
mia in sepsis is conﬂicting. Thus, hypothermia has
shown neuroprotective potential in several intensive
care conditions (for review see Bernard and Buist29),
while a recent study of controlled hypothermia in
patients with meningitis was stopped due to increased
mortality.31 In mice, the septic phenotype, unlike that
Figure 3. Oxygenation of the cortex during changes in inspired
oxygen (FiO2). (a) Oxygen sensor measurements of cortical
oxygenation. (b) Relative changes in oxygen (shown as reciprocal
of fluorescence intensity of the sensor bead) with changes in
FiO2. Data displayed as mean SEM. **p (saline vs 6 h
LPS) 0.01, *p (saline vs 24 h LPS) 0.05; one sided t-test.
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seen in patients, is one of hypothermia with an asso-
ciated increase in illness severity, metabolic shutdown
and mortality.32 We hypothesized that reducing meta-
bolic demand through hypothermia would protect both
endotoxic and healthy mice during the additional bio-
energetic challenge of hypoxemia. Indeed, this was the
case for both spontaneous and controlled (32C) hypo-
thermia where improved preservation of mitochondrial
ﬂavoprotein ﬂuorescence and survival was seen at 6 h
after LPS injection. Instead, the forced recovery of
endotoxic mice to normothermia was detrimental
during progressive hypoxemic insults, suggesting that
the temperature-induced increase in whole body metab-
olism could not be adequately matched by an increase
in mitochondrial ATP production. Many species of
mice hibernate in prolonged cold conditions, so the
hypometabolic response to a severe inﬂammatory
stress (in this case endotoxemia) may represent, at
least in milder forms of sepsis, a speciﬁc adaptive phe-
nomenon in this species.39,40
Extrapolating the present ﬁndings to a human popu-
lation should be done with caution as endotoxemia
initiated by a single LPS injection causes an inﬂamma-
tory condition which is not pathogen-driven, and the
animals in these studies received no resuscitation.
Therefore, further studies are needed to determine
whether the present ﬁndings are replicated in other
models of sepsis.
In conclusion, we report that systemic inﬂammation
leads to increased sensitivity of cortical mitochondria to
hypoxemia and that this increased sensitivity is mir-
rored by a decrease in cortical tissue oxygen tension.
Having revealed a bioenergetics supply–demand imbal-
ance in this endotoxic model, we also show that
Figure 4. Spontaneous hypothermia protects cortical mitochondria from hypoxemia. (a) Changes in cortical flavoprotein signal
during changes in FiO2 in saline- and LPS-injected animals kept at their spontaneous temperature. (b) Quantification of the ratio of
periarterial over perivenular fluorescence in saline- and LPS-injected animals kept at their spontaneous temperature and at 37C. Data
are displayed as mean SEM. **p (6 h LPS 37C vs spontaneous temperature) 0.01.
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reducing metabolic demand through hypothermia
increased survival and reduced the vulnerability of cor-
tical mitochondria during severe hypoxemia.
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